Results for tag: "Lumizyme"

Lumizyme is a drug used to treat endocrine and metabolic disorders. It is a recombinant form of human alpha-galactosidase A, an enzyme that is deficient in patients with Fabry disease. Lumizyme is administered as an intravenous infusion and works by breaking down a type of fat called globotriaosylceramide (Gb3). This helps to reduce the buildup of Gb3 in the body, which can cause damage to the kidneys, heart, and other organs. The Lumizyme market is composed of a variety of companies that produce and distribute the drug. These companies include Genzyme Corporation, Sanofi, and Shire Pharmaceuticals. Additionally, there are a number of generic manufacturers that produce generic versions of the drug. These companies are focused on providing access to the drug to patients in need. Show Less Read more